← All trials
NCT06921486
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2025
- Primary completion
- Aug 31, 2026
- Completion date
- Dec 31, 2026
- First posted
- Apr 10, 2025
- Last posted
- Sep 3, 2025
- Enrollment
- 992
- Arms / groups
- 9 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.Lead sponsor
- Jiao Tong UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.